Kiora Pharmaceuticals, Inc. (KPRX) SEC Filings https://ir.kiorapharma.com/sec-filings/all-sec-filings/rss Kiora Pharmaceuticals, Inc. (KPRX) - All SEC Filings en-us https://d1io3yog0oux5.cloudfront.net/_97e3629f093b7a3eb5d068243dee1637/kiorapharma/files/theme/images/logo-sm.png Kiora Pharmaceuticals, Inc. Logo Equisolve Investor Relations Suite <![CDATA[ARS - Annual Report to Security Holders]]> https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001372514-26-000043/0001372514-26-000043.pdf Fri, 01 May 26 00:00:00 -0400 https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001372514-26-000043/0001372514-26-000043.pdf <![CDATA[DEF 14A - Definitive proxy statements]]> https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001372514-26-000040/0001372514-26-000040.pdf Thu, 30 Apr 26 00:00:00 -0400 https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001372514-26-000040/0001372514-26-000040.pdf <![CDATA[D - Notice of Exempt Offering of Securities]]> https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001372514-26-000038/0001372514-26-000038.pdf Tue, 21 Apr 26 00:00:00 -0400 https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001372514-26-000038/0001372514-26-000038.pdf <![CDATA[8-K - Current report]]> https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001372514-26-000036/0001372514-26-000036.pdf Tue, 07 Apr 26 00:00:00 -0400 https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001372514-26-000036/0001372514-26-000036.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001372514-26-000034/0001372514-26-000034.pdf Thu, 02 Apr 26 00:00:00 -0400 https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001372514-26-000034/0001372514-26-000034.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001372514-26-000032/0001372514-26-000032.pdf Thu, 02 Apr 26 00:00:00 -0400 https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001372514-26-000032/0001372514-26-000032.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001372514-26-000030/0001372514-26-000030.pdf Thu, 02 Apr 26 00:00:00 -0400 https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001372514-26-000030/0001372514-26-000030.pdf <![CDATA[8-K - Current report]]> https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001372514-26-000028/0001372514-26-000028.pdf Thu, 02 Apr 26 00:00:00 -0400 https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001372514-26-000028/0001372514-26-000028.pdf <![CDATA[S-8 - Securities to be offered to employees in employee benefit plans]]> https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001372514-26-000026/0001372514-26-000026.pdf Wed, 25 Mar 26 00:00:00 -0400 https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001372514-26-000026/0001372514-26-000026.pdf <![CDATA[8-K - Current report]]> https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001372514-26-000025/0001372514-26-000025.pdf Wed, 25 Mar 26 00:00:00 -0400 https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001372514-26-000025/0001372514-26-000025.pdf